These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7032807)

  • 21. Lidocaine increases prostacyclin in the rat.
    Casey LC; Armstrong MC; Fletcher JR; Ramwell PW
    Prostaglandins; 1980 Jun; 19(6):977-84. PubMed ID: 6992240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma prostaglandins during the intravenous infusion of angiotensin II in pregnant women.
    Strickland DM; Cox K; McCubbin JH; Whalley PJ; MacDonald PC; Mitchell MD
    Am J Obstet Gynecol; 1984 Dec; 150(8):952-5. PubMed ID: 6391178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin is not a circulating hormone in man.
    Blair IA; Barrow SE; Waddell KA; Lewis PJ; Dollery CT
    Prostaglandins; 1982 Apr; 23(4):579-89. PubMed ID: 7051184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
    J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
    Wilsoncroft PS; Lofts FJ; Griffiths RJ; Moore PK
    J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin production increases during human parturition.
    Ylikorkala O; Mäkäräinen L; Viinikka L
    Br J Obstet Gynaecol; 1981 May; 88(5):513-6. PubMed ID: 7016168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
    Hermán F; Magyar K; Filep JG
    Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY; Lee WH; Quilley CP; McGiff JC
    Fed Proc; 1981 May; 40(7):2001-4. PubMed ID: 7014260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostaglandins and thromboxane in coronary arteriosclerosis].
    Tseluĭko VI; Volkov VI; Simirenko LL; Volodos' NL
    Kardiologiia; 1987 Oct; 27(10):36-9. PubMed ID: 3480387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
    Mileikowsky GN; Nadler JL; Huey F; Francis R; Roy S
    Am J Obstet Gynecol; 1988 Dec; 159(6):1547-52. PubMed ID: 3061301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catabolism of 6 keto PGE1: biological activation by the rat kidney in vitro.
    Moore PK; Griffiths RJ; Gaffen ZA
    Eur J Pharmacol; 1983 Jul; 91(2-3):311-5. PubMed ID: 6684573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
    Oliva D; Nicosia S
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma.
    Machleidt C; Förstermann U; Anhut H; Hertting G
    Eur J Pharmacol; 1981 Aug; 74(1):19-26. PubMed ID: 7032951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G; Deckmyn H; Vermylen J
    Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery increases fetal plasma prostacyclin.
    Leffler CW; Hessler JR; Green RS
    Prostaglandins; 1982 Sep; 24(3):387-96. PubMed ID: 6760254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.